About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, May 21st, 2012

The QualityStocks
Daily Stock List


Synodon, Inc. (SYD.V)

Today we are highlighting Synodon, Inc. (SYD.V), here at the QualityStocks Daily Newsletter.

Founded in 2000, Synodon, Inc. is a remote sensing technology company whose shares trade on the TSX Venture Exchange. The Company developed a leak detection system to detect ground-level gas concentrations. They also focus on the provision of an assortment of datasets. This includes aerial imagery, thermal and terrain mapping, and vegetation and ground type to energy companies. Synodon has their headquarters in Edmonton, Alberta.

Synodon developed the Simultaneous-View Correlation Radiometry (SVCR) technology. They implemented it in the realSens™ gas detection system. SVCR is a variant of the Gas-Filter Correlation Radiometry (GFCR) technique. GFCR is a remote sensing technique. It is used to measure the amount of a gas of interest in the section of an atmosphere located within the field of view of an instrument that employs this technique. It has been used since the 1960's in airborne and space-borne devices - most notably for the MOPITT instrument on-board NASA's Terra polar orbiting satellite.

MOPITT is a radiometer that uses GFCR to measure carbon monoxide (CO) and methane (CH4) in the lower atmosphere. Its main goal is to monitor pollution and its effects in the troposphere. Synodon acquired the rights to expand the technology MOPITT validated in Space to commercial devices and services. The realSens&trade project is Synodon's first undertaking in this respect. It aims primarily at creating an industry standard for the remote sensing of hydrocarbon leaks and emissions.

The realSens™ gas detection system is used for the remote measurement of ground-level gas concentrations from an aircraft flying up to 300 meters in altitude. This includes hydrocarbon emissions, pollution monitoring, industrial emission inventory, hazardous gas monitoring during emergencies, greenhouse gas emission inventory, illegal drug manufacturing detection, chemical weapon monitoring, and other military and security-based applications.

In late April, Synodon announced that their realSens™ technology completed a successful third-party organized blind test. Over the course of the technology development and especially in the last three years, Synodon completed a large number of laboratory and field tests with their realSens™ system. These tests demonstrated the efficacy of the technology at detecting natural gas leaks as low as 100 scfhr (standard cubic feet per hour) and under diverse environmental conditions.

This month, Synodon announced that TECTERRA, Inc. committed an investment of up to $220,000 for the next generation development of the realSens™ technology. The funded improvements to the realSens™ technology are closely based on the recently issued United States patent which Synodon announced on February 21, 2012. They revolve around developing new data analysis methods that use surface reflectivity profiles to improve the accuracy of GFCR measurements. By using this method in their current realSens™ GFCR implementation, Synodon estimates that they can improve the gas detection sensitivity by a factor of up to 10 times.

In addition, this month Synodon announced that in recent flight tests, their realSens™ technology successfully detected simulated ground level liquid hydrocarbon leaks while undergoing deployment at 300 meters altitude in a helicopter flying at 120 km/hr. The Company will now begin marketing this new and innovative leak detection service to liquid hydrocarbon pipeline companies in parallel with their natural gas pipeline leak detection services.

Synodon, Inc. (SYD.V), closed Monday's session at $0.40, up 14.29%, on 16,889 volume. The 52-week low/high is $0.15/$3.00.

Casey Container Corp. (CSEY)

Daytrader Zack, Buying penny stocks, HotStockChat, and FeedBlitz reported previously on CaCasey Container Corp. (CSEY), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Casey Container Corp. engages in the design and custom manufacture of biodegradable PET, HDPE, and other plastic polymer preforms, bottles, and containers. These products are for use in the bottled water, beverage, and consumer products industries. The Company offers biodegradable plastics packaging solutions using the science of the EcoPure® additive and technology. Founded in 2010, Casey Container is based in Scottsdale, Arizona. 

For Preforms, the Company manufactures bulk and custom PET preforms, ready to be blown into bottles at a client's facility. For Plastic Bottles, they manufacture finished PET food-quality bottles. They also manufacture Plastic Containers for household cleaners, shampoos, facial cleansers, lotions, as well as other products. Casey Container includes the best-of-class Eco-Pure® additive in all of their plastics. They do this through a strategic alliance with Bio-Tec Environmental. Casey Container blends innovative biodegradability technology with traditional plastics manufacturing to deliver an environmentally responsible product. PET plastic will be available initially. The Company plans to expand rapidly into other thermoplastics such as HDPE (high-density polyethylene).

EcoPure® is a second-generation additive. When added to a resin type during the manufacturing process, it renders plastics biodegradable. The EcoPure™ technology used to make the Company's plastic packaging solutions biodegradable are useable with polystyrene (PS), polypropylene (PP), polyethyeleneterapthalate (PET), polyethylene (PE), polyvinyl chloride (PVC), and most other types of polymer.

The EcoPure™ technology adds nutrients and other organic compounds that weaken the polymer chain. This allows microbial action to colonize in and around the plastic. The bottles, now completely metabolized, turn into inert humus (biomass), biogas (anaerobic), or Co2 (aerobic).

Casey Container bottles have a shelf life of normal plastic. When placed in an aerobic or anaerobic landfill, their bottles biodegrade in 2-10 years. This depends on the amount of biodegradable additive in the bottle, the gram weight of each bottle/container, and the microbial activity of the landfill it is in.

The Company's bottles can mix into the standard PET recycling stream, while bioplastics cannot. They designed their biodegradable plastic packaging solutions to meet strict standards for shelf life, appearance, and longevity. This makes them especially suited for retail product environments. Casey Container is presently seeking funding to build manufacturing facilities in Florida and Arizona.

Last week, following on their April 2, 2012 Letter of Interest press release, Casey Container announced that they received a Business Valuation Report for their biodegradable plastics business. The Report concludes that a reasonable estimate of the Fair Market Value of a 100 percent interest in Casey is $82.8 million, as of December 31, 2011. Based on their current status, Casey management anticipates beginning production in early October 2012.

Casey Container Corp. (CSEY), closed Monday's trading session at $0.17, even with yesterday’s close, on 2,100 volume. The average volume for the last 60 days is 18,786. The 52-week low/high is $0.03/$0.24.

Midas Medici Group Holdings, Inc. (MMED)

OTCJournal, HotOTCPicks.com, HotOTCBuzz.com, HotPennyInvest.com, JumpingPennyStocks.com, OTCNewsAlerts.com, SmartPennyInvest.com, OTCPennyPicks.com, HotOTCChina.com, and OTCReporter reported earlier on Midas Medici Group Holdings, Inc. (MMED), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Midas Medici Group Holdings, Inc. is a managed IT services and infrastructure company. They supply mid-sized and select enterprises and institutions with leading edge IT solutions in the fields of virtualization, cloud computing and data management. The Company also works with utilities and other institutions to transform the electric grid through digital technologies in the U.S. and Brazil. The Company's mission is to become a leading global provider of green IT and Smart Grid solutions. Midas Medici has their headquarters in New York, New York. 

Across their Cimcorp, StraTech and UtiliPoint brands, Midas Medici works with their customers by optimizing IT and data center investments, streamlining communications between departments, reducing costs and preventing data loss, all while maximizing productivity. The Company has a large and diverse customer base of more than 900 clients. Their worldwide client base includes Pepsi, Red Hat, HP, Oracle, PBS, AT&T, National Grid, GazProm, and the Central Bank of Brazil, CEMIG, the Military Police of Sao Paulo, and the International Monetary Fund (IMF), among others.

Through their UtiliPoint brand, Midas Medici provides custom research, market data and management, technology and policy consulting services to utilities, regulators, and energy industry service providers both domestically and worldwide. They provide these services using multi-disciplinary teams with deep subject matter expertise, highly analytical methodologies, primary research and technology-enabled tools.

Through their Cimcorp and StraTech brands, Midas Medici offers an array of solutions that optimize IT infrastructure and data center investments in Brazil and the U.S., respectively. Seasoned experts deliver innovative data protection, disaster recovery, virtualization, and asset management solutions for mid- size and larger businesses. Midas has the ability to deliver without the constraints of technology and location via a flexible delivery model that spans three datacenter environments: customer-owned, co-location, and the cloud.

Last Friday, StraTech, a brand of Midas Medici, announced that CoLoCSX would provide StraTech Remote Backup Service™, RapidAlert Monitoring, and Disaster Recovery services to their customers. StraTech, formerly Consonus, is a national provider of Data Center, IT Consulting, Infrastructure, and Support Services. Headquartered in Jacksonville, Florida, CoLoCSX is an IT and colocation company that provides managed data center services.

Midas Medici Group Holdings, Inc. (MMED), closed Monday's trading at $0.56, even with yesterday’s close. The average volume for the last 60 days is 3,888. The 52-week low/high is $0.30/$4.00.


Greenbackers reported this month on PAID, Inc. (PAYD), and we highlight the Company, here at the QualityStocks Daily Newsletter.

PAID, Inc. is a one-stop brand management and marketing resource to music, entertainment, and sports personalities and organizations. The Company offers AuctionInc™ online shipping calculation and shopping cart software employing their patented technology to streamline ecommerce. PAID offers turnkey online, mobile, social media and traditional marketing campaigns. They also offer award-winning video & film production, VIP ticketing, web site design, merchandising, ecommerce, as well as fan community management programs. PAID has their headquarters in Massachusetts.

Concerning their Intellectual Property, PAID's shipping calculator patented product, aiShip, offers a solution to providing accurate comparative shipping rates to prospective online-auction bidders. AiShip can handle the always-changing bid of traditional-style auctions, and works for fixed-price listings. The calculator shows a vendor's shipping rates to customers before they bid, and takes into account the current bid, and can configure rates to include taxes, insurance, item, and order handling fees, and more.

The calculator discounts appropriately for multiple items shipped in the same package and handles drop shipping, and offers several other features. A client can provide up to 4 carriers and 38 services to their customers. The Company's shipping calculator technology is in use through the company's aiShip™ software used by hundreds of companies, as well as within numerous e-commerce sites hosted and/or managed by PAID.

PAID launched Rockin' Coffee in October 2011. This is an organic artisanal specialty coffee brand that offers organic, fair trade Arabica coffee blends - fresh-roasted and delivered directly to the consumer. Rockin' Coffee roastmeister Peter Friedland will lead the coffee excellence team's mission to track down, discover and bring to life the most interesting, high-quality coffees from the world's premier coffee farmers.

This past February, PAID announced that Rockin' Coffee won a Design Excellence award for their logo from the Connecticut Art Directors Club (CADC) and is a hit among bloggers. The Rockin' Coffee logo was selected from hundreds of submissions to the CADC, whose mission is to promote the highest standards of excellence in the visual communications arena.

Earlier this month, PAID reported that the Company has been steadily adding clients and growing revenue in 2012 and is on track for their highest revenue ever in 2012.

Mr. Christopher Culross, PAID CFO, stated, "Based on revenue already booked, projects already underway and contracts already signed, we anticipate that 2012 will be PAID's best year financially. New business prospects and other activities currently in the new business pipeline could further increase revenue.  We expect to share a more detailed projection after releasing financial results for yearend 2011 and first quarter 2012."

PAID, Inc. (PAYD), closed Monday's trading at $0.12, down 20.00%, on 274,394 volume with 30 trades. The average volume for the last 60 days is 9,543. The 52-week low/high is $0.10/$0.46.

RXi Pharmaceuticals Corp. (RXII)

StreetInsider, Greenbackers, The Momentum Traders Network, PennyInvest, StockRich, BullRally, CoolPennyStocks, StockEgg, HotOTC, PennyStockVille, and MadPennyStocks reported previously on RXi Pharmaceuticals Corp. (RXII), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Founded in 2011, RXi Pharmaceuticals Corp. is a biotechnology company that lists on the OTC Bulletin Board. The Company focuses on discovering, developing and commercializing innovative therapies based on their proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to 'silence,' or down-regulate, the expression of a specific gene that may be over expressed in a disease condition. RXi Pharmaceuticals has their corporate headquarters in Worcester, Massachusetts.

RXi Pharmaceuticals announced on May 10, 2012 that the Financial Industry Regulatory Authority, Inc., also known as FINRA, approved RXi Pharmaceuticals' common stock for trading under the stock symbol "RXII" on the OTC Bulletin Board. RXi Pharmaceuticals stock began trading, May 10, 2012. The listing of RXi Pharmaceuticals' stock completes their spin-off into an independent, publicly-traded company from former parent Galena Biopharma, Inc. (NASDAQ:GALE). The spin-off transaction was previously announced by Galena in September 2011, and, on April 26, 2012, Galena paid a dividend of one share of RXi Pharmaceuticals common stock for each outstanding share of Galena common stock. 

RXi Pharmaceuticals is building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello. RXi Pharmaceutical's first RNAi product candidate, RXI-109, which targets CTGF (connective tissue growth factor), is scheduled to begin human clinical trials in anti-scarring this year. RXI-109 is a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries. It reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin. The design of RXi's sd-rxRNA compounds are for therapeutic use and have drug-like properties, such as high potency, target specificity, serum stability, reduced immune response activation, and efficient cellular uptake. 

RNAi is a naturally occurring phenomenon where short double-stranded RNA molecules interfere with the expression of targeted genes.  RNAi technology takes advantage of this phenomenon and potentially allows the Company to interfere effectively with particular genes within living cells by designing RNA-derived molecules targeting those genes. RNAi is regarded as a significant advancement in the scientific community. This is evidenced by the journal Science's selection of RNAi as the "Breakthrough of the Year" in 2002 and by the awarding of the 2006 Nobel Prize in Medicine to the co-discoverers of RNAi, including Dr. Craig Mello, a founder of Galena.

This month, RXi Pharmaceuticals announced that Geert Cauwenbergh, Dr. Med. Sc. has been appointed as the Company's President and Chief Executive Officer.  Dr. Cauwenbergh brings more than 30 years of experience in the pharmaceutical industry, including a successful record of accomplishment developing and commercializing dermatological drugs.  Dr. Cauwenbergh will also serve as a Director on the Company's Board.

RXi Pharmaceuticals Corp. (RXII), closed Monday's trading session at $0.11, even with yesterday’s close, on 369,189 volume with 68 trades. The average volume for the last 60 days is 150,738. The 52-week low/high is $0.03/$0.23.

SaveDaily, Inc. (SAVY)

Stock Twiter, Epic Stock Picks, ExclusiveStocks, Stock Legends, PennyStockDayTrader, EpicVIP Group, CashMoneyPlays, Penny Dreamers, and Investor News Source reported on SaveDaily, Inc. (SAVY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SaveDaily, Inc. offers investments and record-keeping services to their intermediary partners, and directly to clients through an assortment of white-labeled interfaces. The Company owns their proprietary financial services platform, which has been in production for approximately three years, helping financial intermediaries succeed in bringing suitable and affordable investment services to everyday savers and investors. SaveDaily lists on the OTC Bulletin Board. SaveDaily conducts their business via their wholly owned subsidiary, SaveDaily.com, Inc., which is headquartered in Seal Beach, California and is a Registered Investment Advisor with the Securities and Exchange Commission (SEC).

SaveDaily's ultra low cost, private label platform enables banks, brokerages, and non-traditional financial service providers to offer, profitably, high-end financial services to anyone, regardless of income, account size, or activity levels. The Company is a pioneer in the field of paperless brokerage solutions. They make it possible for banks to provide their low-income customers with quality investment services, and to do so with attractive margins.

With SaveDaily, account holders can purchase shares of virtually any mutual fund, with no minimums and no transaction fees. The Company provides complete 24×7 web/kiosk/ATM access for opening accounts, making investments, redeeming shares or viewing transaction histories. Clients can invest directly into their mutual fund accounts from their existing checking accounts. They can also set up regularly scheduled deductions from payroll or other sources.

Last week, SaveDaily announced that Carmen Effron, Founder and President of C F Effron Company LLC, would serve on the SaveDaily, Inc. advisory board. C F Effron Company LLC provides strategy and management consulting to numerous banks and credit unions, insurers and reinsurers worldwide. The advisory board assists management with marketing and financial industry best practice strategies.

Ms. Effron joins existing advisory board members and highly respected industry professionals Scott Waite, Chief Financial Officer and Senior Vice President of Patelco Credit Union, Donna McNeely, Senior Vice President, Investments and Insurance, Premier America Credit Union, Scott G. Stathis, Managing Director and COO of Kehrer-LIMRA, and Bart Creedon, Principal and National Director, HSA Products, ACS Mellon.

SaveDaily, Inc. (SAVY), closed Monday's trading session at $0.40, up 14.29%, on 16,889 volume with 11 trades. The average volume for the last 60 days is 15,353. The 52-week low/high is $0.15/$3.00.

Commercial Solutions, Inc. (CSA.TO)

Today we are highlighting Commercial Solutions, Inc. (CSA.TO), here at the QualityStocks Daily Newsletter.

Commercial Solutions, Inc. is one of Canada's leading independent industrial distributors with 23 Services Centers and approximately 270 employees located primarily in Western Canada. The Company offers over 160,000 items critical to maintenance repair and operations (MRO) and original equipment manufacturer (OEM) customers. Commercial Solutions has their headquarters in Edmonton, Alberta. The Company's shares list on the Toronto Stock Exchange.

Commercial Solutions represents 450 leading manufacturers and serves more than 11,000 customer accounts within a broad cross-section of industries. These include oil and gas, forestry, agriculture, firefighting, food processing, chemical processing, mining, utilities, manufacturing, and construction.

Through strategic acquisitions, the Company is working toward continued increases in market share and economies of scale. The day to day operating strategy focuses on improving efficiency and improving their Canadian operations. Their strategy also includes increasing market share of the Canadian industrial supply and related markets and pursuing growth in selected international markets. The Commercial Solutions group of companies provides Business to Business (B2B) service. This includes custom invoicing, pricing, electronic data interchange (EDI) and electronic fund transfers.

Last week, Commercial Solutions announced their financial results for the three-month and six-month periods ended March 31, 2012. The Company reported revenues of $30.5 million, an 8.6 percent growth from the same period in the prior year. EBITDA for the quarter was $1.5 million in comparison to $1.2 million in the same period last year, representing a 25.3 percent improvement. The Company reported net earnings of $0.6 million for the quarter compared to $0.3 million during the same quarter of fiscal 2011.

For the six months ended March 31, 2012, the Company reported revenues of $60.0 million, a 14.3 percent growth from the same period in the prior year. EBITDA for the six months was $2.8 million in comparison to $1.9 million in the same period last year, representing a 43.4 percent improvement. They reported net earnings of $1.0 million for the six months ended March 31, 2012 compared to $0.2 million during the same period in the prior fiscal year.

Commercial Solutions, Inc. (CSA.TO), closed Monday's trading at $0.77, even with yesterday’s close, on 1,200 volume. The 52-week low/high is $0.66/$1.18.

TransBioTec, Inc. (IMLE)

NanoCap Gems and OTCPicks reported previously on Colombia Energy Resources, Inc. (IMLE), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

TransBioTec has developed and patented a non-invasive alcohol sensing system 'SOBR' which works as a type of ignition interlock that functions through transdermal, biometric feedback. The technology works by sensing ethanol alcohol via sweat secretion from the hands. The alcohol sensing system offers a unique solution to the national drunk driving epidemic.

TransBioTec, with three locations, was legally formed as a California "C" corporation on December 31, 2003. TransBioTec's shares trade on the OTC Bulletin Board. The Company has their headquarters in Seal Beach, California.

SOBR technology consists of two parts: the blood alcohol detection technology and the ignition interlock device connected through a microprocessor. SOBR is the first product to market that is entirely neither intrusive nor invasive keeping the vehicles crucial aesthetic appeal to the general population while having the ability to be fitted to any vehicle.

As either a retrofitted or a factory built-in device, the steering wheel of any vehicle becomes the sensor platform. When a driver grasps the steering wheel, the ultra-efficient sensor detects the vapors and determines the precise contents of those vapors, in terms of alcohol level. This information is instantly translated into an engine "start" or "no-start" state.

An unsafe measurement will deny the driver the ability to start the engine of the vehicle. If the driver becomes intoxicated while driving, the car horn and the emergency flashers will go off. If the system is tampered with while parked, the car will not start. If tampered with while driving, the alarms will activate. The driver will not be able to put the vehicle in harm's way.

Last Friday, TransBioTec announced the appointment of Mr. Scott Painter to the position of Chief Executive Officer. Mr. Painter is an experienced Chief Executive with expertise in growing businesses, venture finance, management team development, strategic partnering, as well as mergers and acquisitions. The Board of Directors officially appointed Mr. Painter on May 1, 2012 with the execution of a resolution.

TransBioTec, Inc. (IMLE), closed Monday's trading session at $0.31, down 11.43%, on 19,800 volume with 6 trades. The average volume for the last 60 days is 15,546. The 52-week low/high is $0.15/$1.40.


The QualityStocks
Company Corner


Quantum International Corp. (QUAN)

The QualityStocks Daily Newsletter would like to spotlight Quantum International Corp. (QUAN). Today, Quantum International Corp. closed trading at $2.25, on 17,225 volume with 33 trades. The stock’s average daily volume over the past 60 days is 15,885, and its 52-week low/high is $1.75/$16.50.

Quantum International Corp. announced another step towards their goal of bringing robotic innovation to bear on improving quality of life for people everywhere today, citing last week’s WSJ report on the new collaborative effort (involving Brown, the Department of Veterans Affairs, Massachusetts General Hospital, Harvard Medical School and the German Aerospace Center) that allowed two paralyzed patients to use just their minds to direct a robotic arm, and emphasized how the company is helping to close the loop between breakthrough and commercialization.

Quantum International Corp. (QUAN) is an emerging robotics innovation company that's setting the stage for the next generation of automation technology. The company is targeting leading-edge developers of advanced robotics technologies for acquisition or partnership, with the goal of developing and marketing these technologies to meet fast rising global demand. In particular, the company is exploring new innovations in medical robotics, adding one exploding market on top of another.

With the rapid advancement of sophisticated sensory and control electronics, the promise of economic robotic applications is finally becoming a reality. Although industrial robots have been around for a long time, smaller, lighter, and less expensive versions are finally beginning to play a serious role in the marketplace. It's much like the development of the computer, from a room-size electrical monster, costing millions, to a desktop, laptop, and now handheld electronic wizard that almost anyone can afford.

The worldwide demand for robots is growing rapidly, seen as a now affordable source of controlled energy. The global market for robots is currently estimated at $3.2 billion, with experts projecting the industry to approach $70 billion by 2025. In addition industrial applications, robots are now a crucial part of everyday life for an increasing number of individuals in their home. Personal assistance robots are helping the elderly, paralyzed, and chronically ill lead more independent lives, presenting a major breakthrough in home care with countless benefits.

Add to that the natural growth of the massive health care industry, and medical technology, and it's easy to see why, according to ABI Research, the medical robots industry is expected to reach $1.3 billion by 2016. As an example, various forms of robotic technology are already being used in hospital operating rooms to make difficult or impossible operative procedures now doable. But that same technology can be applied to many other industries, such as consumer electronics, agriculture, wind and solar, and manufacturing. Disclaimer

Quantum International Corp. Company Blog

Quantum International Corp. News:

QUAN Works to Take Robotics Out of the Lab and Into the Marketplace

QUAN: Home Care Robots Could Transform Personal Assistance Market

QUAN: Surgical Robots Move Beyond Human Limits

SilverSun Technologies, Inc. (SSNT)

The QualityStocks Daily Newsletter would like to spotlight SilverSun Technologies, Inc. (SSNT). Today, SilverSun Technologies, Inc. closed trading at $0.20, up 24.22%, on 12,241 volume with 2 trades. The stock’s average daily volume over the past 60 days is 25,430, and its 52-week low/high is $0.005/$0.51.

SilverSun Technologies, Inc. (SSNT), via wholly-owned subsidiary SWK Technologies, is a premier total solutions provider specializing in business software for manufacturers and distributors. Established in 1988, the company focuses on meeting the needs of small-sized and mid-sized businesses ("SMB" marketplace) with accounting and business management products, including SilverSun's own proprietary software. The company also offers its own cloud-based solutions and provides network services (network configuration, data backup, 24/7 remote monitoring, etc.) to its clients.

SilverSun distinguishes itself from traditional software resellers by offering a wide range of value-added services, consisting primarily of programming, training, technical support, and other consulting and professional services. The company also provides software customization, data migration, business consulting, and implementation assistance for complex design environments. Currently, the company has over 1,000 active customers.

In addition to driving organic growth, SilverSun's aggressive growth strategy includes acquiring firms in the extensive and expanding SMB marketplace to create substantial value for its shareholders, employees, and partners. SilverSun aims to leverage SWK Technologies as a platform to roll up and aggregate the best and brightest ERP resellers, as well as other software companies with proprietary products that serve the SMB marketplace. The company's most recent acquisition was in January 2012.

In 2011, SilverSun increased sales 40% over the previous year and strengthened its balance sheet through the elimination of all outstanding debt. With organic sales accelerating, significant debt reduction, and great depth of expertise and resources, SilverSun is well positioned to become a dominant player in the growing business software marketplace. Disclaimer

SilverSun Technologies, Inc. Blog

SilverSun Technologies, Inc. News:

SilverSun Technologies Reports First Quarter 2012 Results

SilverSun Technologies Introduces Proprietary Series of Cloud-Based Business Management Solutions for $8.7 Billion Beer Brewing and Distribution Industry

SilverSun Technologies Issues CEO Letter

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.01, up 11.11%, on 351,000 volume with 10 trades. The stock’s average daily volume over the past 60 days is 217,303, and its 52-week low/high is $0.001/$0.0205.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings wholly-owned subsidiary Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Consorteum Holdings Completes Acquisition of Tarsin Inc.

Consorteum Holdings, Inc. Announces Lead Spokesman for the First Nations MasterCard Program

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.3550, up 1.43%, on 256,292 volume with 50 trades. The stock’s average daily volume over the past 60 days is 177,267, and its 52-week low/high is $0.3412/$1.15.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights

International Stem Cell Corporation Scientists to Present Pre-Clinical Research Results at American Society of Gene and Cell Therapy 15th Annual Meeting

International Stem Cell Corporation Announces New Stem Cell Manufacturing Technologies to Support its Therapeutic Programs

Quantum International Corp. (QUAN) Focuses on Taking Robotics Out of the Lab and Into the Marketplace

Promising new robotics innovations are poised to improve our lives forever, but as of right now many breakthroughs are still years away from commercial availability. Quantum International is dedicated to changing that. The emerging robotics company is exploring new opportunities to shorten the amount of time it takes for some of the world’s most astounding robotics advances to make it to market.

Last week, The Wall Street Journal detailed a new collaboration between researchers at Brown, the Department of Veterans Affairs, Massachusetts General Hospital, Harvard Medical School, and the German Aerospace Center that allowed two paralyzed patients to use their thoughts to direct a robotic arm to grasp objects. This incredible advance in the pursuit of restoring some function to people with paralyzed limbs remains years from practical use for people with paralysis or limb loss.

Quantum International aims to help cut the development time between a laboratory breakthrough, like the one profiled in the Journal, to product commercialization. The executive leadership at QUAN has the experience necessary to advance ideas and patents conceived in university labs into new, independent enterprises.

“The technology is already here—we’ve just got to get it to the marketplace,” stated QUAN CEO Robert Federowicz. “We’re targeting early-stage innovators and research groups with new innovations ready for commercialization and pursuing joint ventures and other deals that would allow us to fund or secure financing for products that could change the face of medicine in the 21st Century.”

“This way, Quantum International can deliver powerful robotics innovations to a hungry marketplace while delivering value to our shareholders,” he added.

QUAN plans to announce its initial business targets in the exciting robotics space soon. For more information on Quantum International’s robotics initiatives, visit www.quantuminternationalcorp.com/investors.html.

EGPI Firecreek, Inc. (EFIR) Updates Market on Q2 Activities, Including Development of Barnett Targets in West Central Texas

EGPI Firecreek today announced serious Q2 momentum drivers, including projected development activities on the 240-acre Boyette Lease, development on the South 40, the completion/sale of 50% of the North 40 interests in their J.B. TUBB Lease, Inc., and sale of their 51% majority interest in Arctic Solar Engineering. EFIR currently operates via wholly-owned subsidiaries, with oil and gas services handled by Chanwest Resources, LLC and resource acquisition through Energy Producers, Inc.

Needless to say it’s been a huge Q2 over at EFIR and projections indicate substantial development activity for the remainder of the interval, with elements like the (previously announced) signing of a Letter of Intent with Cubo Energy, PLC to kick off drilling programs in West Central Texas, as the pair goes after rich Barnett Formation targets. Looking at as little as 10-14 days before definitive agreements with an assignee of Cubo are rendered and then an extensive 3D seismic surveying agenda designed to quantify the 240 acre Boyette site down in Shackelford County, TX.

EFIR also signed a key agreement with Cubo back at the start of March this year, making a $1.15M sale of North 40 oil and gas interests in the J.B. Tubb Leasehold Estate (currently in restructuring due to recent regulatory changes on the Frankfurt Stock Exchange, interest assignments via definitive long form agreement projected within a 10-14 day window). This agreement will place Cubo (or an assignee) in a financing role for the initial sinking of an 8.3k foot well targeting the Ellenburger Formation (on an earn-in basis), as well as setup the framework for additional, planned infrastructural development/participation via an earn-in/financed basis (projected initial CAPEX of some $1.575M).

CEO of EFIR, Dennis Alexander, cited the regulatory environment on the Frankfurt Exchange over the last six months (leading to several unforeseen delays) as the primary mover behind the modification of their agreement with Cubo, reassuring shareholders that requisite changes have since been formulated, and that the clear forward direction established for this relationship has energized both parties.

This relationship will help to facilitate the planned activity in West Central Texas, as Cubo and EFIR pursue specific Barnett Shale characteristics mapped via the 3D seismic work. The receptivity is strong on all accounts, especially geologically speaking, and both companies are eager to get 1-2 horizontals (or an equivalent 8 verticals) in on the Boyette lease as soon as possible.

Mr. Alexander underscored the significance of the drilling programs aimed at developing the Ellenburger Formation, the seismic work being done, and preparatory vectors for realizing some serious Barnett action.

In addition to all this hydrocarbon effort, EFIR announced signing of a Letter of Intent with W2 Energy, Inc., covering the sale of the company’s 51% majority interest in subsidiary Artic Solar Engineering, Inc. (definitive agreement projected within 7-10 days). Mr. Alexander noted the completion of required/audited year-end and unaudited Q1 financial statements by both parties, offering the market a sound benchmark of the deal, as well as projecting a long, healthy relationship between both parties moving forward.

For more information on today’s announcements, or to find out more about EGPI Firecreek, Inc. please visit the company’s website at: www.EGPIFirecreek.com

InVivo Therapeutics Holdings Corp. (NVIV) CEO to Make Several TV Appearances

InVivo Therapeutics Holdings recently announced that the company’s CEO, Frank Reynolds, is scheduled to make appearances on two television news programs. The appearances will occur on Saturday, May 19, and Sunday, May 20, on the channels KXAN-TV and WXYZ-TV, respectively.

Founded in 2005, InVivo is a Cambridge, MA-based company focused on developing technology using polymers to assist patients who are paralyzed from spinal cord injury. InVivo was founded by Robert S. Langer, ScD. Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. The company won the 2011 David F. Apple Award for its outstanding contribution to spinal cord injury medicine.

Reynolds will be discussing InVivo’s new polymer-based treatment that uses a scaffold to provide structural support to a damaged spinal cord, preventing the spinal cord from scarring. Reynolds will also discuss new products under development by InVivo, such as hydrogel technologies. Reynolds’ first TV appearance will be on Austin News Today Weekend, which airs on Saturday, May 19 at 7:20am CDT on KXAN-TV, the local NBC affiliate for the greater Austin, TX area. The second appearance will be on 7 Action News This Weekend, which airs Sunday, May 20 at 8:40am EDT on WXYZ-TV, the local ABC affiliate in Detroit, MI.

“Our technology is a true platform that can be leveraged to create many Neurotrauma products. InVivo is developing technologies to treat chronic injuries like Drew’s, as well as therapies for other nervous system conditions such as chronic pain due to nerve compression and other peripheral nerve injuries. We’re currently under review at FDA for our first SCI treatment, and we look forward to receiving approval to begin those human studies in 2012,” said Reynolds.

China Modern Agricultural Information, Inc. (CMCI) Releases Projected Earnings for the Fiscal Year 2012

China Modern Agricultural today released its projected earnings for the fiscal year ending June 30, 2012. The company’s forecasted net income will have increased by 86% year-over-year to $16.4 million, or $0.35 per basic and diluted earnings per share.

China Modern’s revenue for the first three quarters of fiscal year 2012 was $19.5 million, which represents an increase of $2.3 million, or 13%, as compared to $17.2 million for the three quarters ended March 31, 2011. The company’s gross profit increased by $4.4 million, or 52%, to $13 million. The gross profit margin has improved from 50% to 67% as compared to the same period last year. These increases are primarily due to the company’s adoption of a new business model, which provides China Modern with a revenue stream that incurs very little direct cost, thus improving the gross profit margin.

In November of 2011, China Modern successfully acquired 100% ownership of Shangzhi Yulong Cattle Industry Co. Ltd., generating a bargain purchase gain of $5.72 million that has been consolidated in the quarterly financial statements ended Dec. 31, 2011.

For the three quarters ended March 31, 2012, China Modern’s net income increased by $8.4 million, or 149%, to $14 million, as compared with $5.7 million for the three quarters ended March 31, 2011. The company’s net profit margin increased from 33% to 72%, and the earnings per share increased from $0.14 to $0.31, which was an increase of $0.17 or 120%.

The company’s projected earnings for the fiscal year ended June 30, 2012 are anticipated to be approximately $27.6 million, which represents an increase of $2.6 million, or 10%, as compared with $25 million for the same time frame in the previous year. Revenues from raw milk sales are forecasted to be $18.3 million, and sales commission from farmers is projected to be $9.3 million. The company’s forecasted gross profit is $18 million, which is an increase of $5 million, or 38%. The gross profit margin is anticipated to increase from 52% to around 65%. China Modern’s anticipated net income is $16.4 million, which represents an increase of around $7.6 million, or 86%, as compared to the same period in 2011. The company’s projected net profit margin will have increased to 59%, up from 35%, and the earnings per share is forecasted to rise from $0.23 to about $0.35, which is an increase of 52% year-over-year.

China Modern Agricultural is a high-tech livestock company that specializes in breeding cows and calves, producing and selling milk, and selling organic fertilizer directly to suppliers. The company additionally provides livestock breeders with specialized livestock technical consultation, cow breeding technical support, and agricultural information support. The company’s farmland is located in the Heilongjiang Province, which has a humid continental climate that is ideal for the growth of grass, which, in turn, is essential for grazing and feeding cattle and aids in the company’s cow and calf breeding, raw milk production, and organic fertilizer production.

For more information, visit the company’s Web site at www.hljzhongxian.com/zx/eng_zx/index.asp


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251